GLUT1 and CAIX expression profiles in breast cancer correlate with adverse prognostic factors and MCT1 overexpression

Histology and Histopathology

Volumn 26, Issue 10, 2011, Pages 1279-1286

  Pinheiro, Céline ^a,b   Sousa, Bárbara ^c   Albergaria, André ^a,c   Paredes, Joana ^c   Dufloth, Rozany ^d   Vieira, Daniella ^e   Schmitt, Fernando ^c,f   Baltazar, Fátima ^a,b  

^a UNIVERSITY OF MINHO   (Portugal)

^b UNIVERSITY OF MINHO   (Portugal)

^c UNIVERSITY OF PORTO   (Portugal)

^d PONTIFÍCIA UNIVERSIDADE CATÓLICA DE CAMPINAS   (Brazil)

^e FEDERAL UNIVERSITY OF SANTA CATARINA   (Brazil)

^f University of Porto   (Portugal)

Author keywords

Breast carcinoma; CAIX; CD147 EMMPRIN; GLUT1; Immunohistochemistry; Monocarboxylate transporters (MCTs)

Indexed keywords

CA9 PROTEIN, HUMAN; CARBONATE DEHYDRATASE; COTRANSPORTER; GLUCOSE TRANSPORTER 1; MONOCARBOXYLATE TRANSPORT PROTEIN 1; MONOCARBOXYLATE TRANSPORTER; MUSCLE PROTEIN; SLC16A4 PROTEIN, HUMAN; SLC2A1 PROTEIN, HUMAN; TUMOR ANTIGEN; TUMOR MARKER;

ARTICLE; BIOSYNTHESIS; BREAST TUMOR; CANCER STAGING; FEMALE; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENETICS; HUMAN; IMMUNOHISTOCHEMISTRY; KAPLAN MEIER METHOD; METABOLISM; PATHOLOGY; PROGNOSIS; TISSUE MICROARRAY;

ANTIGENS, NEOPLASM; BREAST NEOPLASMS; CARBONIC ANHYDRASES; FEMALE; GENE EXPRESSION; GENE EXPRESSION PROFILING; GLUCOSE TRANSPORTER TYPE 1; HUMANS; IMMUNOHISTOCHEMISTRY; KAPLAN-MEIER ESTIMATE; MONOCARBOXYLIC ACID TRANSPORTERS; MUSCLE PROTEINS; NEOPLASM STAGING; PROGNOSIS; SYMPORTERS; TISSUE ARRAY ANALYSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 80053319008     PISSN: 02133911     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Baumann M.U., Zamudio S. and Illsley N.P. (2007). Hypoxic upregulation of glucose transporters in BeWo choriocarcinoma cells is mediated by hypoxia-inducible factor-1. Am. J. Physiol. Cell Physiol. 293, C477-485.
2. Chen C.L., Chu J.S., Su W.C., Huang S.C. and Lee W.Y. (2010). Hypoxia and metabolic phenotypes during breast carcinogenesis: expression of HIF-1α, GLUT1, and CAIX. Virchows Arch. 457, 53-61.
3. Chia S.K., Wykoff C.C., Watson P.H., Han C., Leek R.D., Pastorek J., Gatter K.C., Ratcliffe P. and Harris A.L. (2001). Prognostic significance of a novel hypoxia-regulated marker, carbonic anhydrase IX, in invasive breast carcinoma. J. Clin. Oncol. 19, 3660-3668.
4. Chiche J., Ilc K., Laferriere J., Trottier E., Dayan F., Mazure N.M., Brahimi-Horn M.C. and Pouyssegur J. (2009). Hypoxia-inducible carbonic anhydrase IX and XII promote tumor cell growth by counteracting acidosis through the regulation of the intracellular pH. Cancer Res. 69, 358-368.
5. Emens L.A. and Davidson N.E. (2003). The follow-up of breast cancer. Semin. Oncol. 30, 338-348.
6. Ganapathy V., Thangaraju M. and Prasad P.D. (2009). Nutrient transporters in cancer: relevance to Warburg hypothesis and beyond. Pharmacol. Ther. 121, 29-40.
7. Gatenby R.A. and Gillies R.J. (2004). Why do cancers have high aerobic glycolysis? Nat. Rev. Cancer 4, 891-899+899.
8. Gatenby R.A., Gawlinski E.T., Gmitro A.F., Kaylor B., Gillies R.J. (2006). Acid-mediated tumor invasion: a multidisciplinary study. Cancer Res. 66, 5216-5223.
9. Helmlinger G., Sckell A., Dellian M., Forbes N.S. and Jain R.K. (2002). Acid production in glycolysis-impaired tumors provides new insights into tumor metabolism. Clin. Cancer Res. 8, 1284-1291.
10. Hussain S.A., Ganesan R., Reynolds G., Gross L., Stevens A., Pastorek J., Murray P.G., Perunovic B., Anwar M.S., Billingham L., James N.D., Spooner D., Poole C.J., Rea D.W. and Palmer D.H. (2007). Hypoxia-regulated carbonic anhydrase IX expression is associated with poor survival in patients with invasive breast cancer. Br. J. Cancer 96, 104-109.
11. Izumi H., Torigoe T., Ishiguchi H., Uramoto H., Yoshida Y., Tanabe M., Ise T., Murakami T., Yoshida T., Nomoto M. and Kohno K. (2003). Cellular pH regulators: potentially promising molecular targets for cancer chemotherapy. Cancer Treat. Rev. 29, 541-549.
12. Kang S.S., Chun Y.K., Hur M.H., Lee H.K., Kim Y.J., Hong S.R., Lee J.H., Lee S.G. and Park Y.K. (2002). Clinical significance of glucose transporter 1 (GLUT1) expression in human breast carcinoma. Jpn. J. Cancer Res. 93, 1123-1128.
13. Kirk P., Wilson M.C., Heddle C., Brown M.H., Barclay A.N. and Halestrap A.P. (2000). CD147 is tightly associated with lactate transporters MCT1 and MCT4 and facilitates their cell surface expression. EMBO J. 19, 3896-904.
14. Koukourakis M.I., Giatromanolaki A., Harris A.L. and Sivridis E. (2006). Comparison of metabolic pathways between cancer cells and stromal cells in colorectal carcinomas: a metabolic survival role for tumor-associated stroma. Cancer Res. 66, 632-637.
15. Macheda M.L., Rogers S. and Best J.D. (2005). Molecular and cellular regulation of glucose transporter (GLUT) proteins in cancer. J. Cell. Physiol. 202, 654-662.
16. Mathupala S.P., Parajuli P. and Sloan A.E. (2004). Silencing of monocarboxylate transporters via small interfering ribonucleic acid inhibits glycolysis and induces cell death in malignant glioma: an in vitro study. Neurosurgery 55, 1410-1419.
17. Mathupala S.P., Colen C.B., Parajuli P. and Sloan A.E. (2007). Lactate and malignant tumors: a therapeutic target at the end stage of glycolysis. J. Bioenerg. Biomembr. 39, 73-77.
18. Matos I., Dufloth R., Alvarenga M., Zeferino L.C. and Schmitt F. (2005). P63, cytokeratin 5, and P-cadherin: three molecular markers to distinguish basal phenotype in breast carcinomas. Virchows Arch. 447, 688-694.
19. Perez de H.F., Wood I.S. and Trayhurn P. (2010). Hypoxia stimulates lactate release and modulates monocarboxylate transporter (MCT1, MCT2, and MCT4) expression in human adipocytes. Pflugers Arch. 459, 509-518.
20. Pinheiro C., Longatto-Filho A., Scapulatempo C., Ferreira L., Martins S., Pellerin L., Rodrigues M., Alves V.A., Schmitt F. and Baltazar F. (2008a). Increased expression of monocarboxylate transporters 1, 2, and 4 in colorectal carcinomas. Virchows Arch. 452, 139-146.
21. Pinheiro C., Longatto-Filho A., Ferreira L., Pereira S.M., Etlinger D., Moreira M.A., Jube L.F., Queiroz G.S., Schmitt F. and Baltazar F. (2008b). Increasing expression of monocarboxylate transporters 1 and 4 along progression to invasive cervical carcinoma. Int. J. Gynecol. Pathol. 27, 568-574.
22. Pinheiro C., Longatto-Filho A., Simoes K., Jacob C.E., Bresciani C.J., Zilberstein B., Cecconello I., Alves V.A., Schmitt F. and Baltazar F. (2009a). The prognostic value of CD147/EMMPRIN is associated with monocarboxylate transporter 1 co-expression in gastric cancer. Eur. J. Cancer 45, 2418-24.
23. Pinheiro C., Longatto A., Pereira S.M.M., Etlinger D., Moreira M.A.R., Jube L.F., Queiroz G.S., Schmitt F. and Baltazar F. (2009b). Monocarboxylate transporters 1 and 4 are associated with CD147 in cervical carcinoma. Dis. Markers 26, 97-103.
24. Pinheiro C., Albergaria A., Paredes J., Sousa B., Dufloth R., Vieira D., Schmitt F. and Baltazar F. (2010). Monocarboxylate transporter 1 is up-regulated in basal-like breast carcinoma. Histopathology 56, 860-867.
25. Sonveaux P., Vegran F., Schroeder T., Wergin M.C., Verrax J., Rabbani Z.N., De Saedeleer C.J., Kennedy K.M., Diepart C., Jordan B.F., Kelley M.J., Gallez B., Wahl M.L., Feron O. and Dewhirst M.W. (2008). Targeting lactate-fueled respiration selectively kills hypoxic tumor cells in mice. J. Clin. Invest. 118, 3930-3942.
26. Span P.N., Bussink J., Manders P., Beex L.V. and Sweep C.G. (2003). Carbonic anhydrase-9 expression levels and prognosis in human breast cancer: association with treatment outcome. Br. J. Cancer 89, 271-276.
27. Swietach P., Vaughan-Jones R.D. and Harris A.L. (2007). Regulation of tumor pH and the role of carbonic anhydrase 9. Cancer Metastasis Rev. 26, 299-310.
28. Tan E.Y., Yan M., Campo L., Han C., Takano E., Turley H., Candiloro I., Pezzella F., Gatter K.C., Millar E.K., O'Toole S.A., McNeil C.M., Crea P., Segara D., Sutherland R.L., Harris A.L. and Fox S.B. (2009). The key hypoxia regulated gene CAIX is upregulated in basal-like breast tumours and is associated with resistance to chemotherapy. Br. J. Cancer 100, 405-411.
29. Trastour C., Benizri E., Ettore F., Ramaioli A., Chamorey E., Pouyssegur J. and Berra E. (2007). HIF-1alpha and CA IX staining in invasive breast carcinomas: prognosis and treatment outcome. Int. J. Cancer 120, 1451-1458.
30. Ullah M.S., Davies A.J. and Halestrap A.P. (2006). The plasma membrane lactate transporter MCT4, but not MCT1, is up- regulated by hypoxia through a HIF-1alpha-dependent mechanism. J. Biol. Chem. 281, 9030-9037.
31. Vaupel P., Harrison L. (2004). Tumor hypoxia: causative factors, compensatory mechanisms, and cellular response. Oncologist 9 (Suppl. 5), 4-9.
32. Vleugel M.M., Greijer A.E., Shvarts A., van der G.P., van B.M., Aarbodem Y., van T.H., Harris A.L, van Diest P.J. and van der Wall E. (2005). Differential prognostic impact of hypoxia induced and diffuse HIF-1alpha expression in invasive breast cancer. J. Clin. Pathol. 58, 172-717.
33. Vordermark D. and Brown J.M. (2003). Endogenous markers of tumor hypoxia predictors of clinical radiation resistance? Strahlenther Onkol. 179, 801-811.
34. Wilson M.C., Meredith D., Fox J.E., Manoharan C., Davies A.J. and Halestrap A.P. (2005). Basigin (CD147) is the target for organomercurial inhibition of monocarboxylate transporter isoforms 1 and 4: the ancillary protein for the insensitive MCT2 is EMBIGIN (gp70). J. Biol. Chem. 280, 27213-27221.
35. Wykoff C.C., Beasley N.J., Watson P.H., Turner K.J., Pastorek J., Sibtain A., Wilson G.D., Turley H., Talks K.L., Maxwell P.H., Pugh C.W., Ratcliffe P.J. and Harris A.L. (2000). Hypoxia-inducible expression of tumor-associated carbonic anhydrases. Cancer Res. 60, 7075-7083.
36. Younes M., Brown R.W., Mody D.R., Fernandez L. and Laucirica R. (1995). GLUT1 expression in human breast carcinoma: correlation with known prognostic markers. Anticancer Res. 15, 2895-2898.